Gentle aerobic exercise eased fibromyalgia pain, no hard intensity needed

Fibromyalgia brings widespread pain alongside fatigue and low mood, and exercise is a standard recommendation despite many people fearing that activity will make symptoms worse. The authors note that neither the efficacy nor the optimal type and volume of aerobic exercise had actually been established. That leaves the practical questions unanswered: whether the pool or the pavement is better, how hard to push, and how often. This review set out to compare aerobic exercise against control conditions and to pit different forms of aerobic exercise against each other.

The reviewers searched the Cochrane Library, EMBASE, MEDLINE, PsychInfo and SPORTDISCUS through April 2009, along with the reference lists of earlier studies and reviews. They included randomised trials comparing aerobic exercise with controls, which ranged from treatment as usual to attention placebo and active therapy, plus head-to-head comparisons of different exercise types. Two authors independently extracted data using predefined fields that included study quality indicators. Twenty-eight trials compared aerobic exercise with controls and seven compared exercise types, covering 2,494 patients, and results were pooled using random effect models.

After treatment, aerobic exercise reduced pain with a standardised effect of 0.31, fatigue 0.22, depressed mood 0.32 and limitations of health-related quality of life 0.40, while physical fitness improved by 0.65, the largest effect in the set. Pain was significantly reduced by both land-based and water-based programmes at slight to moderate intensity performed two or three times per week. Benefits for depressed mood, quality of life and physical fitness were still present at follow-up, and continuing to exercise was associated with those positive outcomes. Risk of bias analyses did not undermine the results, but few trials described their protocols in enough detail for subgroup comparisons.

The findings support aerobic exercise as a legitimate part of fibromyalgia management rather than an optional extra, and they push back on the idea that harder training is required for symptom relief. The effects are consistent in direction but modest in magnitude, which matters when setting expectations. Because so few trials reported detailed exercise protocols, the head-to-head question of which type of aerobic exercise suits whom remains open. The authors conclude a programme should run for at least 4 weeks, leaving longer-term durability and the role of ongoing motivation as the next questions.

This is a reason to think that low-key, regular aerobic activity can shift fibromyalgia symptoms, and that the intensity needed appears to be well below punishing. The gains reported were real but small, so it is fairer to expect gradual easing of pain, fatigue and mood than a dramatic turnaround. The pooled trials suggest the format is flexible: water-based and land-based exercise both showed pain reduction, which may matter if weight-bearing activity is uncomfortable. The follow-up pattern also hints that whatever benefit accrues is tied to carrying on rather than completing a block and stopping.